2019 Laboratory Coding Update

If you were challenged by the coding and billing of laboratory and pathology services in 2018, expect your difficulties to ramp up in 2019. For starters, there are many new and deleted CPT^®/HCPCS codes specific to molecular pathology and other services. Compounding matters, our experts have observed a lot of lingering confusion related to the use of PLA codes, coding and billing for drug-of-abuse testing, documentation requirements and more. One webcast, presented by top laboratory coding and billing authority Robin Zweifel, can help fill the void on all counts. You'll take away knowledge that empowers you to neutralize the threats to your revenues and prevent auditor action.

Learning Objectives:

• Understanding 2019 CPT/HCPCS code changes specific to clinical laboratory and pathology services, including molecular pathology and genetic sequencing procedures, along with appropriate code use
• Updated information on Proprietary Laboratory Analyses (PLA) codes — what they are and what they mean for laboratories
• Updated AMA and CMS guidelines pertaining to documentation, coding and billing for laboratory and pathology service
• Impacts of the 2019 Clinical Laboratory Fee Schedule on lab payments
• How changes to date-of-service rules for certain gene-based procedures will affect the cost of doing business and your revenue stream
• Minimizing the documentation and coding risks associated with drug-of-abuse testing and other lab services, plus the corrective action you need to take when errors are detected
• How charge capture and claim processing workflows and claim edit resolution may actually be reducing your reimbursements
• Determining the accuracy of medical necessity edits driving the ABN process for your location
• Any other potential high-risk topics, including audit related, for laboratory and pathology services in 2019
• Time permitting, answers to attendee questions

CPT^® is a registered trademark of the American Medical Association.